New York Oncology Hematology (NYOH) - Clifton Park Cancer Center — Albany, New York

New York Oncology Hematology (NYOH) - Clifton Park Cancer Center is a clinical research site located in Albany, New York, United States 12206.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

New York Oncology Hematology (NYOH) - Clifton Park Cancer Center has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Prostate Cancer.

Sponsors: Eli Lilly and Company.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Albany

Browse all research sites in New York · View every site in Albany

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New York Oncology Hematology (NYOH) - Clifton Park Cancer Center?

New York Oncology Hematology (NYOH) - Clifton Park Cancer Center has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New York Oncology Hematology (NYOH) - Clifton Park Cancer Center conducted?

New York Oncology Hematology (NYOH) - Clifton Park Cancer Center has 1 clinical trials on record, with 1 currently active. Their work covers Prostate Cancer.

Is New York Oncology Hematology (NYOH) - Clifton Park Cancer Center accredited by Crixeo Clinical Trials?

New York Oncology Hematology (NYOH) - Clifton Park Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about New York Oncology Hematology (NYOH) - Clifton Park Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.